A collection of articles on the challenges as well as the emerging strategies that support commercialization for the cell and gene therapy sector.
This eBook is a collection of articles written from September 2018 through May 2019 that covers some of the commercialization challenges facing the cell and gene therapy industry and the data-driven strategies that drive marketability. Indeed, as the cell and gene therapy landscape continues to mature, so too do the intricacies of commercialization. Inside the pages of this eBook, you’ll find insightful data that will help industry professionals address the challenges critical for the sustainability of cell and gene therapy business models. From potential barriers to commercial success and supply chain recalibration to payment and reimbursement, this eBook explains the emerging commercialization strategies necessary to tackle these critical and timely topics.